Background {#Sec1}
==========

Severe degenerative calcific aortic stenosis (cAS) affects 3% of the over 75 year-olds and leads to heart failure and death unless the valve is replaced. Coexisting cardiac amyloid - typically wild-type Transthyretin (wtATTR) has been reported but has not been systematically studied: its prevalence and prognostic significance are unknown. Multiparametric CMR (function, LGE, T1 and ECV mapping) has high sensitivity and specificity for cardiac amyloidosis. We sought, in cAS, to define the prevalence of occult cardiac amyloid by biopsy, subtype it, explore its CMR presentation and understand its prognostic significance.

Methods {#Sec2}
=======

As part of the RELIEF-AS study (NCT 02174471), 146 patients with severe AS awaiting aortic valve replacement (AVR) underwent CMR (LGE, T1 mapping) and intra-operative myocardial biopsies. 108 patients had calcific AS (cAS) \[75 ± 6 years; 58% male\]; the remainder had bicuspid (36), rheumatic (1) or unicuspid AS (1). Biopsies were screened for cardiac amyloid by congo red staining; if positive, tissue was fully sub-typed (immunohistochemistry, mass spectrometry as needed), and patients underwent full clinical amyloid assessment including genotyping and DPD (bone tracer) scintigraphy.

Results {#Sec3}
=======

Myocardial biopsy identified amyloid depositions in 6 out of 108 cAS patients (all age \>65 years); none in the other cohorts. All were TTR. All were by genotyping wild-type. Two had definite cardiac amyloidosis by CMR and DPD, but were not recognized by routine pre-operative work-up (Figure [1](#Fig1){ref-type="fig"}). Four other patients had findings by multiparametric CMR that could be explained solely by severe AS (Table [1](#Tab1){ref-type="table"}). At median follow-up of 1.9 years (0.4-4.2 years), 50% of the affected patients had died compared to 7.8% in the remaining cAS cohort. This was highly significant and, of all parameters assessed, the presence of TTR amyloid had the highest hazard ratio for death (HR 9.4 \[2.4-35.6\], *p = 0.001,* univariable Cox regression analysis).Table 1Pre-operative characteristics of patients with TTR on cardiac biopsyPatient 1Patient 2Patient 3Patient 4Patient 5Patient 6**Age/Gender**73 female69 male80 female85 male84 male71 male**Biopsy/Genotype**TTR/wild-typeTTR/wild-typeTTR/wild-typeTTR/wild-typeTTR/wild-typeTTR/wild-type**CMR LGE pattern\***AmyloidosisAmyloidosisASASASAS**ECV**60%52%31%25%32%32%**LV mass index (g/m** ^**2**^ **)**13715011710193132**DPD Scintigraphy**Grade 2Grade 2NAGrade 1NAGrade 1**Peak AV Gradient (mmHg)**74457011061116**AVAi (cm** ^**2**^ **/m** ^**2**^ **)**0.360.520.60.340.350.24**Follow-up Status**AliveDeadDeadAliveDeadAlive\*LGE pattern consistent with diagnosis of cardiac amyloidosis / aortic stenosis (AS)Figure 1**Occult Transthyretin Amyloid Deposition in Aortic Stenosis; detected by CMR late gadolinium enhancement (LGE), histological congo red staining and DPD scintigraphy; Transthyretin deposits are associated with poor outcome in aortic stenosis (Kaplan-Meier-Plot)**.

Conclusions {#Sec4}
===========

Occult cardiac amyloid (wild-type TTR) has a prevalence of 6% in cAS undergoing surgical AVR (mean age 75). It has a poor outcome even when at low levels of infiltration. Multiparametric CMR becomes diagnostic in 1/3, but early disease looks like the changes of AS - here, DPD scanning adds value.
